Search research articles
Contact Us
Filters
Showing results (61-70 of 69) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 69 results.
Molecular Neurobiology
|
July 29, 2020
Temporally Altered miRNA Expression in a Piglet Model of Hypoxic Ischemic Brain Injury
Sophie Casey, Kate Goasdoue, Stephanie M Miller, et al.
Archives of Disease in Childhood. Fetal and Neonatal Edition
|
January 19, 2026
Effect of enteral arachidonic acid and docosahexaenoic acid supplementation on brain volumes at term in preterm infants: a secondary outcome analysis of a randomised controlled trial
William Hellström, Pia Lundgren, Anders K Nilsson, et al.
JCI Insight
|
October 5, 2018
Thrombocytopenia is associated with severe retinopathy of prematurity
Bertan Cakir, Raffael Liegl, Gunnel Hellgren, et al.
Frontiers in Pediatrics
|
November 9, 2020
Randomized Control Trial of Postnatal rhIGF-1/rhIGFBP-3 Replacement in Preterm Infants: <i>Post-hoc</i> Analysis of Its Effect on Brain Injury
Sandra Horsch, Alessandro Parodi, Boubou Hallberg, et al.
Nature Reviews. Neurology
|
November 4, 2015
Bumetanide for neonatal seizures-back from the cotside
Ronit M Pressler, Geraldine B Boylan, Neil Marlow, et al.
JAMA
|
March 27, 2019
Association Between Year of Birth and 1-Year Survival Among Extremely Preterm Infants in Sweden During 2004-2007 and 2014-2016
Mikael Norman, Boubou Hallberg, Thomas Abrahamsson, et al.
JAMA Pediatrics
|
February 1, 2021
Effect of Enteral Lipid Supplement on Severe Retinopathy of Prematurity: A Randomized Clinical Trial
Ann Hellström, Anders K Nilsson, Dirk Wackernagel, et al.
The Lancet. Neurology
|
March 14, 2015
Bumetanide for the treatment of seizures in newborn babies with hypoxic ischaemic encephalopathy (NEMO): an open-label, dose finding, and feasibility phase 1/2 trial
Ronit M Pressler, Geraldine B Boylan, Neil Marlow, et al.
The Journal of Pediatrics
|
November 26, 2018
rhIGF-1/rhIGFBP-3 in Preterm Infants: A Phase 2 Randomized Controlled Trial
David Ley, Boubou Hallberg, Ingrid Hansen-Pupp, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 69) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 69 results.
Molecular Neurobiology
|
July 29, 2020
Temporally Altered miRNA Expression in a Piglet Model of Hypoxic Ischemic Brain Injury
Sophie Casey, Kate Goasdoue, Stephanie M Miller, et al.
Archives of Disease in Childhood. Fetal and Neonatal Edition
|
January 19, 2026
Effect of enteral arachidonic acid and docosahexaenoic acid supplementation on brain volumes at term in preterm infants: a secondary outcome analysis of a randomised controlled trial
William Hellström, Pia Lundgren, Anders K Nilsson, et al.
JCI Insight
|
October 5, 2018
Thrombocytopenia is associated with severe retinopathy of prematurity
Bertan Cakir, Raffael Liegl, Gunnel Hellgren, et al.
Frontiers in Pediatrics
|
November 9, 2020
Randomized Control Trial of Postnatal rhIGF-1/rhIGFBP-3 Replacement in Preterm Infants: <i>Post-hoc</i> Analysis of Its Effect on Brain Injury
Sandra Horsch, Alessandro Parodi, Boubou Hallberg, et al.
Nature Reviews. Neurology
|
November 4, 2015
Bumetanide for neonatal seizures-back from the cotside
Ronit M Pressler, Geraldine B Boylan, Neil Marlow, et al.
JAMA
|
March 27, 2019
Association Between Year of Birth and 1-Year Survival Among Extremely Preterm Infants in Sweden During 2004-2007 and 2014-2016
Mikael Norman, Boubou Hallberg, Thomas Abrahamsson, et al.
JAMA Pediatrics
|
February 1, 2021
Effect of Enteral Lipid Supplement on Severe Retinopathy of Prematurity: A Randomized Clinical Trial
Ann Hellström, Anders K Nilsson, Dirk Wackernagel, et al.
The Lancet. Neurology
|
March 14, 2015
Bumetanide for the treatment of seizures in newborn babies with hypoxic ischaemic encephalopathy (NEMO): an open-label, dose finding, and feasibility phase 1/2 trial
Ronit M Pressler, Geraldine B Boylan, Neil Marlow, et al.
The Journal of Pediatrics
|
November 26, 2018
rhIGF-1/rhIGFBP-3 in Preterm Infants: A Phase 2 Randomized Controlled Trial
David Ley, Boubou Hallberg, Ingrid Hansen-Pupp, et al.
Page
of 7